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Recent restrictions on the testing of cosmetic ingredients 
in animals have resulted in the need to test the genotoxic 
potential of chemicals exclusively in vitro prior to licensing. 
However, as current in vitro tests produce some misleading 
positive results, sole reliance on such tests could prevent some 
chemicals with safe or beneficial exposure levels from being 
marketed. The 3D human reconstructed skin micronucleus 
(RSMN) assay is a promising new in vitro approach designed 
to assess genotoxicity of dermally applied compounds. The 
assay utilises a highly differentiated in vitro model of the 
human epidermis. For the first time, we have applied auto-
mated micronucleus detection to this assay using MetaSystems 
Metafer Slide Scanning Platform (Metafer), demonstrating 
concordance with manual scoring. The RSMN assay’s fixa-
tion protocol was found to be compatible with the Metafer, 
providing a considerably shorter alternative to the recom-
mended Metafer protocol. Lowest observed genotoxic effect 
levels (LOGELs) were observed for mitomycin-C at 4.8 µg/
ml and methyl methanesulfonate (MMS) at 1750 µg/ml when 
applied topically to the skin surface. In-medium dosing with 
MMS produced a LOGEL of 20 µg/ml, which was very simi-
lar to the topical LOGEL when considering the total mass 
of MMS added. Comparisons between 3D medium and 2D 
LOGELs resulted in a 7-fold difference in total mass of MMS 
applied to each system, suggesting a protective function of 
the 3D microarchitecture. Interestingly, hydrogen peroxide 
(H2O2), a positive clastogen in 2D systems, tested negative in 
this assay. A  non-genotoxic carcinogen, methyl carbamate, 
produced negative results, as expected. We also demonstrated 
expression of the DNA repair protein N-methylpurine-DNA 
glycosylase in EpiDerm™. Our preliminary validation here 
demonstrates that the RSMN assay may be a valuable follow-
up to the current in vitro test battery, and together with its 
automation, could contribute to minimising unnecessary in 
vivo tests by reducing in vitro misleading positives.
Introduction
An understanding of the genotoxic effects of chemicals in 
humans is imperative for the prediction of genotoxic potential 
resulting from chemical exposure. This is particularly important 
for chemicals utilised in products and treatments with repeated 
human exposure, such as cosmetics, pharmaceuticals and 
food. Further, following the 7th Amendment to the Cosmetics 
Directive in 2009, use of laboratory animals in cosmetics 
testing has been banned in the European Union (1). Due to the 
fact that in vivo testing has previously been heavily relied upon 
to confirm positive results of in vitro genotoxicity assays, it is 
now vital that in vitro tests alone can accurately identify human 
carcinogens (2). However, in vitro tests often exaggerate toxic 
effects when compared with in vivo results, possibly due to lack 
of normal human tissue structure or dosing strategies being 
unrealistic. Further, some in vitro tests have used p53-deficient 
cell lines, which tend to be over-sensitive for genotoxic 
endpoints compared to normal human cells, contributing to 
misleading positives (3). Therefore, improvement of the current 
in vitro test battery is urgently required, to allow chemicals with 
safe, or even beneficial, human exposure levels to be identified 
and subsequently utilised in products and treatments (2).
3D EpiDerm™ reconstructed human skin models
An alternative to the current genotoxicity test battery is the 
inclusion of in vitro methods that mimic human tissues, such 
as EpiDerm™ 3D reconstructed human skin models (1). Such 
models are predicted to better reflect the microarchitecture 
of human tissues and more accurately recapitulate human 
metabolism than cell lines. They are also predicted to exhibit 
near-normal DNA repair and cell cycle control (1,4). It has 
been demonstrated that 87% of tested xenobiotic metabolising 
enzymes were expressed consistently between the EpiDerm™ 
model and human skin, further supporting the relevance to the 
human condition (5). As skin is an organ frequently exposed 
directly to chemicals, particularly via dermal application of 
cosmetics and occupational exposure, the EpiDerm™ models 
represent one of the most common human chemical exposure 
routes (1). The stratum corneum of EpiDerm™ provides more 
relevant exposure conditions for target cells during topical 
dosing, avoiding the non-physiological concentrations of test 
chemical that are often used in in vitro tests (1,4). Therefore, 
an advantage of such models is that realistic concentrations of 
chemicals may be tested, with any associated kinetic effects that 
may occur as the test article diffuses from the epidermal surface 
to the basal layer of proliferating keratinocytes (4). Additionally, 
the reconstructed skin micronucleus (RSMN) assay has been 
shown to detect some chemicals that require metabolic activation 
(6). Previous studies utilising this assay have established that it is 
reproducible between laboratories in the USA and Europe, and 
also that it correctly classifies chemicals into either genotoxic 
or non-genotoxic carcinogens (1,2,5). Application of test 
chemicals to the medium instead of topically may also serve 
as a basic model of systemic exposure to chemicals. The hair 
dye ingredient, p-phenylenediamine (PPD), has previously been 
added to medium of EpiDerm™ models by Hu et al. (7), who 
noted cytotoxicity and evidence of PPD metabolites (7). An aim 
of this study was to expand the database for the RSMN assay in 
another European laboratory and to explore medium exposure 
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in more depth. To our knowledge, this is the first publication 
exploring the use of models from MatTek’s Slovakia laboratory.
Exploring genotoxic dose responses in 3D systems
In recent years, experimental techniques for the detection 
of genotoxicity have become more sensitive, allowing more 
accurate detection of genotoxic dose responses. This has led 
to non-linear dose responses, for example, threshold dose-
responses, being described (8,9). The demonstration of non-
linear dose responses has led to the suggestion that low doses of 
a genotoxin may not pose a risk to health, unlike higher doses. 
Cellular resistance to genetic damage at low doses may be due 
to homeostatic maintenance by DNA repair (10), insufficient 
levels of chemical traversing cell membranes (bioavailability) 
or the genotoxin reacting with molecules within the cytoplasm 
and surroundings (8). As most human exposures occur at 
low doses, it is vital that low-dose effects are studied. While 
genotoxic thresholds have been well characterised in 2D cell 
culture, they have not yet been fully investigated with 3D 
approaches. Furthermore, previous studies involving the 3D 
EpiDerm™ models have been primarily used for evaluating 
whether chemicals induce a positive response for micronuclei 
in this assay, rather than for obtaining complete dose responses. 
The parameters—no observed genotoxic effect level and lowest 
observed genotoxic effect level (LOGEL)—are currently used 
to define non-linear dose responses at low doses (9) but require 
substantial statistical power. Therefore, by applying an automated 
micronucleus scoring platform, as discussed in the next section, 
to the RSMN assay, such analyses of the low-dose region can be 
performed in 3D cultures. Given the aforementioned advantages 
of the RSMN assay, defining the low-dose region in primary 
cells with 3D microarchitecture maybe more robust. With recent 
interest in the effects of low-dose genotoxicity, this is the first 
study to investigate the effects in the low-dose region (i.e. a 
low-dose range which is several fold lower than that for toxic 
effects) in 3D culture. The non-linear parameters will be used 
as a convenient comparison between 2D and 3D and not to 
define thresholds for the chemicals used. We have investigated 
low doses of three direct-acting, model genotoxins that have 
previously tested positive for genotoxic thresholds in vitro in 
human lymphoblastoid cell lines (9,11).
Use of the Metafer Slide Scanning Platform with the 
RSMN assay
While the RSMN assay has successfully detected genotoxicity 
of some chemicals in 3D EpiDerm™ models in previous studies, 
the scoring for micronuclei was completed manually. In this 
study, an automated approach, using the MetaSystems Metafer 
Slide Scanning Platform (Metafer), was introduced for the first 
time to detect micronuclei in keratinocytes isolated from 3D 
EpiDerm™ models. As manual scoring is laborious and partially 
subjective, use of the Metafer to identify micronucleus induction 
in 3D EpiDerm™ keratinocytes minimises delays associated 
with time-consuming manual scoring and reduces subjectivity 
(12). The automated approach also results in more cells being 
scored than with manual scoring. Therefore, we investigated the 
application of the Metafer in the RSMN assay, using the RSMN 
assay’s currently recommended harvest protocol (13).
The objective of this study was to evaluate the use of the 
RSMN assay in our laboratory for characterisation of the gen-
otoxicity dose responses for low doses of four chemicals of 
diverse mechanism of action and to validate the Metafer system 
for use as a more efficient method for micronucleus scoring in 
keratinocytes from the RSMN assay.
Materials and methods
Chemicals
Chemicals were purchased from Sigma-Aldrich (Gillingham, UK) and stored 
according to the manufacturer’s instructions.
EpiDerm™ tissues
Tissues were purchased from MatTek In Vitro Life Science Laboratories 
(Bratislava, Slovakia) and ordered 3 weeks in advance. All tissues shipped to 
Swansea were derived from cells from the same donor (Keratinocyte strain: 
4F1188), as confirmed by MatTek. There are 24 tissues in one batch, and this 
work represents data generated from ~28 individual batches and, therefore, ship-
ments. Following overnight shipping, tissues were kept at 4°C until assay com-
mencement, with the time spent at 4°C standardised between batches to ensure 
that transfer to 37°C was completed at the same time on the day of arrival.
Assessing growth of EpiDerm™ during the RSMN assay
Each day during a typical RSMN assay, EpiDerm™ tissues were sectioned and 
stained using haematoxylin and eosin (H&E) at Singleton Hospital, Swansea. 
Sections were analysed using the ×100 objective of an Olympus BX51 light 
microscope. Size of the stratum corneum was taken as an indicator of cell 
growth and differentiation (Figure 1).
RSMN assay
Tissue inserts were inspected for morphological defects, such as blisters. Excess 
moisture on the surface of the tissue was removed by gentle blotting with sterile 
gauze. Tissues were placed into 6-well plates with each well containing 900 µl 
of new maintenance medium (NMM) (MatTek) pre-warmed to 37°C. Tissues 
were incubated overnight under standard culture conditions (37°C, 5% CO2 
humidified atmosphere). After 16 h, the NMM within the well was aspirated 
and replaced with 900 µl sterile 37°C NMM containing 3 µg/ml cytochalasin 
B (cytoB) (Sigma-Aldrich). Test articles were dissolved and diluted in acetone 
(Fisher Scientific, Loughborough, UK). Ten microlitres of test article was 
administered onto the topical surface using a positive displacement pipette and 
the plate rotated for even distribution. Tissues were incubated under standard 
conditions for 24 h. On Day 3, the treatment protocol was repeated and the 
models incubated for a further 24 h with fresh test article.
All tissues were harvested within 48 ± 3 h after the first treatment, according 
to Curren et al. (14) and as mentioned previously. For successful trypsin diges-
tion, each tissue was submerged in 5 ml Dulbecco’s phosphate-buffered saline 
(DPBS; Invitrogen, Paisley, UK) for 15 min at room temperature (RT) prior 
to transfer to 5 ml ethylenediaminetetraacetic acid (EDTA), pH 8.0 (Ambion, 
Warrington, UK), diluted to 1 mg/ml in DPBS, for 15 min at RT. The tissue 
inserts were blotted before transfer to 1 ml 0.25% Trypsin–EDTA pre-warmed 
to 37°C (Invitrogen). An additional 400  µl of trypsin solution was added 
directly into the insert and incubated at 37°C for 15 min. After this time, tissues 
were carefully removed from the insert using sterile fine forceps and placed in 
fresh trypsin solution (1 ml). To maximise cell recovery, the insert was rinsed 
thoroughly and the aforementioned 400 µl was combined with the 1 ml in the 
well. The resulting 1.4 ml of the cell suspension was added to 1 ml Dulbecco’s 
modified Eagle’s medium (Invitrogen) (supplemented with foetal bovine serum 
(10%) (Invitrogen)) to inactivate trypsin.
For in-medium dosing, 10 µl of a stock concentration of methyl methanesul-
fonate (MMS) was added directly into the medium (890 µl), with the dilution fac-
tor accounted for, and mixed. For the mononucleate assay, cytoB was not added 
to the NMM and tissues were harvested 24 h later than for the binucleate assay.
Cell fixation
Cell suspensions were centrifuged at 100  × g for 5 min and the supernatant 
aspirated. One millilitre of potassium chloride (KCl, 75 mM; Sigma-Aldrich) 
pre-warmed to 37°C was added slowly to the pellet. After 3 min at RT, 3 ml of 
fixative (3:1 methanol:acetic acid; Fisher Scientific) chilled to 4°C was added. 
Cells were kept in fixative at 4°C awaiting slide preparation.
Slide preparation and staining for manual scoring
Cells in fixative were centrifuged at 100 × g for 5 min at 4°C, the supernatant 
removed and 5 µl of the cell pellet gently pipetted onto a clean, dry slide as a 
concentrated dot to minimise cell spreading. Following air drying, slides were 
stained for 3 min using acridine orange (Sigma-Aldrich) diluted to 40 µg/ml in 
Gurr phosphate buffer (0.1 M NaH4PO4, 0.1 M Na2HPO4) at pH 6.8 (Gibco). 
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Slides were rinsed in Gurr phosphate buffer and left to de-stain for 30 min 
in fresh Gurr phosphate buffer. Micronucleus frequencies were assessed by 
visualisation under UV light on an Olympus BX50 microscope, using ×100 
objective. One thousand binucleated cells were scored for the presence of 
micronuclei and cell viability assessed by binucleate frequency in 500 cells. 
Cells with a cytoplasm stained green were excluded from binucleate and micro-
nucleus scores, as these are highly differentiated keratinocytes.
Slide preparation and staining for automated scoring
For the comparison of automated and manual scoring methodologies, slides 
for automated scoring were prepared from the same cell pellet used for manual 
scoring. Following preparation for manual scoring, 200 µl fixative was added 
and 100 µl of cell suspension was distributed over the entire surface of a wet 
slide cleaned using 70% ethanol prior to soaking in water. Cell density was 
adjudged under a light microscope and, if required, the volume of fixative 
amended accordingly. Once air dried, slides were stored at −20°C awaiting 
staining. Slides were evenly covered with 20 µl Vectashield Mounting Medium 
with 4′,6-diamino-2-phenylindole (Vector Laboratories, Peterborough, UK), 
coverslip applied and kept in the dark for 15 min prior to automated scoring 
using the Metafer system
Assessment of micronucleus frequency using Metafer
Micronucleus detection in binucleated cells was performed using the param-
eters specified by A. L. Seager et al. (13). As described by Seager et al., param-
eters for analysis of micronuclei were developed using cell lines. In our studies, 
Metafer parameters developed for cell lines were unchanged in the analysis of 
micronuclei in cells from EpiDerm™. Metafer was allowed to systematically 
scan the slide using the ×10 objective and following scanning, all binucleated 
cells identified as containing a micronucleus were confirmed by reanalysis of 
the image by a trained scorer using the ×100 objective. All images of binucle-
ates in the on-screen gallery, which were predicted to not contain micronu-
clei by Metafer, were also confirmed to be true negatives. Gallery images that 
appeared to contain a micronucleus were assessed further under ×100 objective 
(Supplementary Figure 1, available at Mutagenesis Online). Therefore, with the 
need for by-eye confirmation, Metafer analysis could perhaps be considered to 
currently be a semi-automated scoring approach, rather than fully automated. 
The criteria for classification of micronuclei, as recommended by Fenech et al. 
(15), were used to characterise micronuclei. Binucleate frequency was scored 
manually under a Carl Zeiss Axio Imager fluorescence microscope and micro-
nucleus frequency scored using this microscope with the Metafer 4 software, 
version 3.5 (MetaSystems, Altlussheim, Germany). Separate software for the 
analysis of frequency of mononucleates, binucleates and multinucleates for cell 
lines is available for Metafer but was not used in these studies. Approximately 
500 cells were scored for binucleate frequency per tissue and 1000 cells were 
scored for presence of micronuclei. A final micronucleus frequency score was 
generated based on the number of true micronucleus events following by-eye 
confirmation. A  previously optimised mononucleate classifier was used to 
detect mononucleates.
Preparation of positive control
Two 10  µl applications of a 6  µg/ml solution of mitomycin-C (MMC; 
0.1875 µg/cm2) over 48 h were distributed uniformly over the 0.64 cm2 topical 
surface area. This gave consistent statistically significant increases in micronu-
cleus frequencies over solvent (negative) controls (2).
Collaboration with Procter and Gamble Laboratories
To further compare Metafer and manual scoring approaches, Procter and 
Gamble (P&G), a company that has been involved with validation of the RSMN 
Fig. 1. Images of H&E-stained sections documenting the EpiDerm™ skin models for the duration of the assay, during which, the stratum corneum’s thickness 
increased from 21.8 to 58.3 µm (A−D). No discernable morphological differences were observed after either 24 or 48 h following application of water (E and 
F) or acetone (G and H). Only after 48 h, binucleated cells were observed (J). t = time (h). Vertical lines represent the distance measured for estimation of the 
thickness of the stratum corneum (top) and the remainder of the tissue model (bottom). 
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assay, shipped slides to Swansea University for Metafer analysis. The assay 
was completed in P&G’s laboratories in the USA and slides were prepared for 
Metafer analysis using the fixation and slide preparation protocol described 
previously. Slides were shipped coded to Swansea University, stained and 
analysed using Metafer, as outlined previously. Comparative acridine orange 
(manual) scoring was completed in P&G’s laboratories.
DNA repair gene expression analysis
Following the second chemical treatment, cells were harvested as previously out-
lined, for tissues treated topically with 0, 1000 and 1900 µg/ml MMS. Following 
centrifugation at 100 × g, supernatant was removed and total RNA extracted from 
the pellet using the RNeasy Kit (Qiagen, Crawley, UK) and RNase-free DNase 
Set (Qiagen). Eluted RNA solution was quantified using the NanoDrop (ND 
1000) Spectrophotometer, software version 3.1.2. Synthesis of complementary DNA 
(cDNA) was performed via reverse transcription of 1 µg RNA using the Quantitect 
Reverse Transcription Kit (Qiagen) and BioRad T100 Thermal Cycler using con-
ditions specified by the manufacturer. The polymerase chain reaction (PCR) was 
performed for each cDNA sample, using the GoTaq® Flexi DNA Polymerase 
kit (Promega, Southampton, UK). N-methylpurine-DNA glycosylase (MPG) 
primers (Sigma-Aldrich): Forward primer: GGTCCGAGTCCCACGAAGCC. 
Reverse primer: CTGCATGACCTGGGCCCCG. β–actin (housekeep-
ing gene): Forward primer: GATGGCCACGGCTGCTTC. Reverse primer: 
TGCCTCAGGGCAGCGGAA. Polyacrylamide gels (5.4%) were cast and DNA 
polyacrylamide gel electrophoresis (PAGE) performed at 170 V for 30 min. DNA 
was stained by washing the gel for 7 min in 1 g/l silver nitrate solution (Sigma-
Aldrich), followed by a 3 min wash in sodium hydroxide/formaldehyde solution 
(Sigma-Aldrich) until the bands were visible, followed by submersion in ddH2O.
Micronucleus detection in a human lymphoblastoid cell line
TK6 cells were seeded at a density of 1 × 105 cells/ml in RPMI 1640 medium 
(Gibco, Paisley, UK) [supplemented with 10% horse serum (Gibco) and 1% 
glutamine (Gibco)]. After 24 h incubation at 37°C and 5% CO2, cells were dosed 
for 24 h with MMS diluted in H2O. Following the dosing period, medium was 
replaced with fresh medium and a further 24 h recovery period was allowed. 
Samples were then harvested using the standard Metafer harvest protocol, as 
described by A. L. Seager et al. (13). A mononucleate classifier was used to 
detect micronuclei in mononucleates and determine micronucleus frequency, 
using the aforementioned Metafer protocol.
Statistical analysis
A two-tailed Fisher’s exact test was used to assess whether statistically significant 
(P ≤ 0.05) differences exist between control and treated sample micronucleus 
frequencies and to predict LOGELs. Doses demonstrating a statistically signifi-
cant increase in micronuclei above control levels are indicated on graphs by an 
asterisk. All error bars represent standard deviation around the mean of three 
biological replicates. Pearson’s product moment correlation was used to deter-
mine whether a correlation exists between two separate treatments, where a cor-
relation coefficient, r, of +1 is a total positive correlation, 0 is no correlation and 
−1 is a total negative correlation. The Broken Stick Model (16) was used to pre-
dict whether the data fitted a threshold or linear dose response for genotoxicity. 
Unless otherwise stated in figure legends, each data point is the mean (±SD) of 
three tissues, with each, where possible, from a separate shipment of Epiderm™ 
models, thus representing three biological replicates in cases where n = 3.
Results
Using three clastogens with different mechanisms of action 
(MMC, MMS and H2O2), for which there is a wealth of in vitro 
micronucleus data available, we evaluated the practicality of 
the RSMN assay as an advancement in traditional cell culture 
techniques for modelling genotoxicity and constructing dose-
responses. A  non-genotoxic carcinogen, methyl carbamate, 
was also included to validate the specificity of the assay and 
use of the Metafer Slide Scanning Platform. Dose ranges were 
selected using preliminary dose-finding studies with escalating 
doses applied until 50% toxicity (TD50) was reached, based on 
binucleate frequency values.
Morphology of Epiderm™ models
Sectioning and visualisation of these models was simple, 
effective and could prove useful in examining the absorption 
kinetics through skin by similar approaches. We established the 
morphological changes over time of untreated tissues and those 
treated with acetone, the recommended solvent, and water, our 
preferred solvent (Figure 1). No discernable differences were 
observed between the treatments but, crucially, water gave 
much lower binucleate frequencies than untreated and acetone-
treated tissues (data not shown). Therefore, despite our initial 
reservations, acetone appears to be the most applicable solvent.
From our experiences with the assay, we were able to observe 
how the tissues responded to various conditions. For example, 
delivery of the models was at 4°C overnight from Bratislava 
and the manufacturers state that tissues are stable for 6 days at 
this temperature. On one occasion, tissues were delayed by 24 h 
but were without observable defects. Although the vital statis-
tics are within the expected range for a working assay (1,14), 
several batches were compromised, presumably during transit, 
and had poor cell yield. Such tissues had a distinct pink colora-
tion once the topical surface had been blotted dry of residual 
medium following unpacking. It seems likely that the observed 
pink colouration was due to a leak in the polymer at the bot-
tom of each tissue support, leading to movement of media into 
the tissue. Remnants of dried medium remained on the topical 
surface, giving the appearance of a red ring around the perim-
eter of some tissues, which could not be removed by sterile 
gauze. However, this had no adverse effect on tissue behaviour. 
Incidentally, blotting the topical surface to remove condensa-
tion accumulated during transit was important for ensuring 
optimal development of the models. This step was omitted on 
one occasion and this appeared to reduce binucleate frequency.
Reproducibility
Low inter-batch variability (where a batch is defined as an 
individual plate of 24 tissues; each batch was usually shipped 
independently, unless two batches were ordered to arrive in 
one package) was generally observed in tissues processed in 
our laboratory, suggesting that the assay is reproducible and 
supporting previous findings (2). It is also worth noting that as 
the same donors are used for tissues cultured in both MatTek’s 
USA and Slovakia laboratories (S. Letasiová, MatTek, 
personal communication), direct comparisons between the 
two MatTek laboratories is a possibility. Historical solvent 
control data from our laboratory were concordant with levels 
of previous studies (1,2), with a micronucleus frequency of 
0.05% (±0.05%, n  =  26) (Figure  2). Historical binucleate 
frequency for the solvent control was 52.9 ± 7.75%, which 
also corresponded with previous studies and was within the 
expected range (2,17).
MMC positive control data were also reproducible 
(0.8 ± 0.64%) (n  =  18) (Figure  3). Although caution is urged 
with regard to large inter-batch variation received over an 
18-week period, our positive control data remain significantly 
greater than solvent control (Figure  3). Previous inter-labo-
ratory studies have demonstrated variation in micronucleus 
induction at 6 µg/ml MMC, with frequencies <0.7% reported 
which are still significantly greater than solvent control lev-
els (2). Further, our historical positive control micronucleus 
frequency is also around 14× greater than the solvent con-
trol frequency, yet it is clear that the aforementioned overlap 
is an observation that would need addressing for regulatory 
acceptance. Interestingly, the historical positive control binu-
cleate frequency of 44.2 ± 9.04% is remarkably similar to 
that observed in three USA-based laboratories, which ranged 
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from 40.9 to 47.1% (2). Overall cell yield was also within the 
ranges achieved in previous studies (2), according to trypan 
blue-based cell counting from early batches, which generally 
yielded between 180 000 and 345 000 cells.
LOGELs for topical MMS treatments in other laboratories 
ranged between 600 and 1000 µg/ml (1,2). Considering the inevi-
table, if slight, variation between laboratories performing the 
assay, and distributors and donors of the models (2), these figures 
are within around 3× of our LOGEL for topical MMS of 1750 µg/
ml, a relatively minor variation. As mentioned previously, varia-
bility was also observed for binucleate frequency at high doses of 
H2O2, yet micronucleus frequency remained at background levels.
The mononucleate assay is less sensitive than the binucleate 
assay for detection of micronuclei
To validate the influence of cytokinesis block for the RSMN 
assay’s sub-acute dosing approach (two separate doses of cytoB 
and test chemical, rather than a single, acute dose, as per 2D), the 
mononucleate assay was performed (Figure  2). Micronucleus 
frequency for the binucleate assay in 3D tissues was greater 
than for the mononucleate assay for the three test articles 
investigated: there was a 2.9-fold difference for acetone, 3.4-
fold for 6 µg/ml MMC positive control and 2.3-fold for MMS 
treatment. However, only MMC gave a statistically significant 
difference between mononucleate and binucleate frequency.
Applicability of the Metafer for detecting micronucleus 
events in keratinocytes
Tissues were treated with a solvent control and 6 µg/ml MMC 
per day for 2  days to elicit a positive response. From the 
same tissue, slides were prepared and stained for manual and 
automated scoring methods allowing for a direct comparison 
(Figure 3). Although Metafer produced a greater micronucleus 
frequency than manual for MMC, a strong positive correlation 
(r  =  0.921) was observed between the two methodologies, 
indicating their congruency. There was no significant 
difference between the two methodologies for the solvent 
control (P  <  0.05), and although Metafer was again slightly 
greater, producing 0.07% compared to 0% for manual, the 
Metafer value fell within the expected range (14). Due to the 
advantages of automation over manual methods, automated 
scoring was preferred and hereafter utilised in the detection 
of micronuclei. We also found that counting samples of cells 
upon harvesting with trypan blue, as recommended by MatTek 
In Vitro Life Science Laboratories, did not give reproducible 
scores for toxicity. Instead, binucleate frequency was used as a 
toxicity measure, as mentioned previously.
MMC produced a LOGEL for micronucleus induction when 
applied topically
In this assay, 48  µg/ml MMC (a total of 1.5  µg/cm2 over 
48 h) was found to be the TD50. The TD50 achieved was 
greater than that reported in the literature, possibly due to 
differences in miscibility of MMC, although the reason for 
this is unknown and warrants further investigation (2). The 
dose–response in Figure 4 was at low doses of MMC, at least 
4-fold lower than the TD50 to establish low-dose trends. Doses 
up to 3.6 µg/ml MMC did not cause a significant increase in 
micronucleus frequency compared to the solvent control. The 
lowest alpha value was P  =  0.685 at 1.2  µg/ml MMC. The 
lowest dose causing significant micronucleus induction over 
the solvent control was 4.8  µg/ml for topical application of 
MMC (P = 0.03) (Figure 4A), thus representing the LOGEL. 
However, subsequent broken stick dose–response modelling 
(16) (Figure  4B), used to define a threshold doses in non-
linear dose responses, found no evidence of a threshold and 
therefore, the null hypothesis of a linear dose–response cannot 
be rejected (P > 0.05). The model may, however, be skewed by 
the variation at higher doses.
H2O2 and methyl carbamate did not cause an increase in 
micronucleus frequency when applied topically
Topical administrations of doses of H2O2 exceeding 35 mg/
ml (>1.1 µg/cm2) caused substantial blistering of the stratum 
Fig. 2. The frequency of mononucleates and binucleates containing a 
micronucleus (%), according to the mononucleate assay (no cytoB added) and 
corresponding binucleate assay tissues (n = 3), respectively. Approximately 
2000 cells were scored per replicate for the mononucleate assay using Metafer. 
Two 10 µl topical applications of 6 µg/ml (0.1875 µg/cm2) MMC or 1750 µg/
ml (54.6875 µg/cm2) MMS were administered over 48 h. A statistically 
significant difference was observed between mononucleate and binucleate 
micronucleus frequency for MMC (P = 0.02), while acetone (P = 0.20) and 
MMS 1750 µg/ml (P = 0.07) did not demonstrate a significant difference 
between the two assays. Binucleate frequencies for samples with cytoB 
added: acetone, 58.02 ± 2.36%; MMC, 47.34 ± 2.43%; MMS, 49.29 ± 4.76%. 
*Represents a P ≤ 0.05 relative to the mononucleate assay.
Fig. 3. Comparison of frequency of micronucleus events in binucleated cells 
obtained via manual and automated methods of scoring (n = 3). Pearson’s 
product moment correlation indicated a very strong positive correlation 
between the manual and automated scores for 6 µg/ml MMC treatments 
(r = 0.921). A strong positive correlation was obtained for 3 µg/ml MMC 
(r = 0.520). No statistically significant difference was observed between 
manual and automated scores for the solvent (acetone) control. Historical 
micronucleus frequencies for Metafer for solvent control (26 tissues) and 
6 µg/ml MMC (18 tissues) are also included.
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corneum but failed to elicit a positive micronucleus response 
(Figure 5A). It is interesting to note that other parameters may 
play a role in determining ‘maximum tolerated doses’ other 
than the TD50 in 3D models. The highest dose of H2O2 tested for 
micronucleus induction (50 mg/ml) caused a 45% reduction in 
binucleate frequency compared to control without an increase in 
micronuclei events. However, there was considerable variation 
between tissues where binucleate frequency, following 
treatment with 60 mg/ml, which ranged from 45 to 12.5%, 
thereby giving misleading TD50 values, which could impact on 
hazard identification by these models (3).
In other studies performed within our laboratory, Metafer 
has consistently given slightly higher micronucleus frequen-
cies than manual scoring. We questioned the specificity of 
the Metafer and whether this slight over-exaggeration would 
lead to false positives. Therefore, methyl carbamate, a non-
genotoxic carcinogen, was used to validate the specificity of 
the assay and scoring approach. Methyl carbamate elicited a 
negative response for micronucleus induction, with no LOGEL 
(P > 0.05) (Figure 5B). Using a non-genotoxin suggests that 
there is concordance between manual and Metafer scoring, and 
that the Metafer is not likely to over-predict micronucleus fre-
quency. The doses used here were 100-fold greater than those 
previously used in vitro to conclude that methyl carbamate is 
non-genotoxic (18). Despite this, toxicity was not observed at 
these higher doses for methyl carbamate in EpiDerm™ mod-
els. Higher doses (up to 800 µg/ml, data not shown) resulted 
in a reduction of binucleate frequency to 39.1%, without an 
increase in micronucleus frequency (n = 2). As TD50 was not 
observed, the dose range utilised was perhaps not optimal.
MMS induced LOGELs for both topical and medium dosing
We explored topical and medium application of the well-
characterised methylating agent and clastogen, MMS. Initially, 
the selected topical dose range was based upon previous studies 
where increases in micronucleus frequency above solvent 
control levels were obtained (1,2). When these were found to 
Fig. 5. Dose responses for frequencies of micronuclei and binucleated cells (%) for (A) H2O2 (n = 3) and (B) Methyl carbamate (n = 2). No statistically 
significant differences were observed between the solvent control and treated samples (P > 0.05).
Fig. 4. (A) Dose response for frequencies of micronuclei and binucleated cells at low doses of MMC. A LOGEL was found at 4.8 µg/ml (P = 0.004). Subsequent 
broken stick modelling (B) of these data did not discount a linear response for micronucleus induction (P = 0.3). *Represents a P ≤ 0.05 relative to the untreated control.
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give negative results in our laboratory, higher doses were tested 
until binucleate frequency decreased to <50% of control tissues. 
Topical application with MMS produced a LOGEL at 1750 µg/ml 
(54.69 µg/cm2) (Figure 6A). Addition of MMS directly into the 
medium produced a LOGEL of 20 µg/ml (Figure 6C). Whereas 
broken stick modelling suggests a threshold dose–response for 
topical application (P = 0.047) (Figure 6B), the medium dose–
response is, interestingly, linear (P = 1) (Figure 6D).
The EpiDerm™ models express MPG mRNA
To assess whether 3D tissues express DNA repair genes relevant 
to the methylating agent used in this study, expression of the 
glycosylase MPG was measured in RNA extracted from 3D 
models. In addition, to examine dose-dependent differences in 
DNA repair enzyme expression following topical treatment of 
the EpiDerm™ models with MMS, reverse transcription–PCR 
was performed and visualised using DNA PAGE for MPG. 
Following treatment, no notable dose-dependent differences 
were observed for MPG expression (Figure 7). Although not 
quantitative, levels appeared consistent throughout samples, 
supporting expression of this DNA repair enzyme in the 
EpiDerm™ models. Inclusion of a sample of RNA from human 
lymphoblastoid cell line TK6 for comparison (Lane 10) suggests 
slightly higher expression of MPG in the EpiDerm™ tissues 
compared to TK6 cells.
Discussion
This study further validates the RSMN assay with the 
EpiDerm™ 3D human skin model and supports its use in the 
in vitro genotoxicity test battery, particularly when assessing 
cosmetic ingredients. For the first time, we have linked these 
3D skin models with automated micronucleus detection 
Fig. 6. (A) Dose–response for frequencies of micronuclei and binucleated cells (%) for MMS applied topically (n = 3). LOGEL = 1750 µg/ml (54.69 µg/cm2) 
(P = 0.002). (B) Broken stick model analysis (16) for data in Figure 6A indicates a non-linear dose–response (P = 0.01). (C) Dose–response for frequencies of 
micronuclei and binucleated cells (%) for MMS applied to medium (n = 3). LOGEL = 20 µg/ml (0.625 µg/cm2) (P = 0.047). Binucleate frequency fell to <50% 
relative population doubling at doses of 50 µg/ml (n = 3). (D) Broken stick model analysis (16) for data in Figure 6C indicates a linear dose–response (P = 1). 
*Represents a P ≤ 0.05 relative to the untreated control. 
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using an image analysis system (Metafer). We have used this 
approach to generate robust dose responses for four chemicals, 
which have allowed initial comparisons with genotoxicity in 
traditional 2D cell culture systems.
Success of inter-laboratory transfer of RSMN methodology
Initial RSMN assays were performed as detailed by Mun et al. (1). 
Accordingly, 3 µg/ml MMC was used to cause a positive response, 
where micronucleus frequency exceeded 1%. However, in our 
hands, 3 µg/ml failed to produce such an effect (Figure 3) and 6 µg/
ml MMC was used instead. Similarly, a higher dose of MMS was 
needed (1750 µg/ml) to produce a statistically significant increase 
in micronucleus frequency over the solvent control compared to 
previous laboratories’ findings (600 µg/ml) (1), although this was 
a relatively minor variation, as mentioned previously. The reason 
for the observed variation is unknown, but this would need to be 
addressed for standardisation of the RSMN assay.
Furthermore, differences between dose responses for the 
same chemicals in different laboratories may be due to technical 
(i.e. chemical preparation and/or dosing techniques), Metafer-
based, or donor-related differences within our approach com-
pared to that of previous studies. Such inevitable variations 
could be due to chemical preparation and dosing technique, 
for example. Inter-batch variation within a laboratory, as men-
tioned previously, may also play a role. The lower background 
micronucleus frequency of EpiDerm™ models compared to 
cell lines is possibly due to greater genetic stability of primary 
keratinocytes within the tissues, compared to genetically trans-
formed cell lines, where background micronucleus frequency is 
potentially more than 10-fold greater (9). This further supports 
the use of such approaches for providing a more representative 
model of human exposure in vitro than current approaches.
Automation of micronucleus detection in the RSMN assay
We have demonstrated the Metafer’s potential for automating 
micronucleus detection in the RSMN assay. We have also found 
that the assay’s shorter cell fixation protocol is compatible 
with Metafer analysis and, therefore, with further validation, 
this protocol might be adapted as a standard harvest protocol 
for Metafer, reducing time and materials required compared 
to the current harvest procedure for cell culture experiments. 
Furthermore, a negative result for methyl carbamate, a non-
genotoxic carcinogen, confirmed that Metafer is unlikely to elicit 
false-positive micronucleus frequency results for non-genotoxic 
chemicals, despite showing exaggerated micronuclei frequencies 
compared to manual methods for genotoxins. Given this, we are 
confident that Metafer analysis is specific for positive genotoxins.
To further validate the use of Metafer in micronucleus quan-
titation in the RSMN assay, three coded chemicals, MMC, 
N-ethyl-N-nitrosourea and etoposide, were scored using 
our Metafer System and results compared to manual scor-
ing performed at P&G Laboratories (USA) (Figure  8). In all 
cases, methodologies showed remarkable similarity in dose-
responses. Importantly, this comparison demonstrated that, for 
the majority, automated scoring correctly distinguished positive 
results from concurrent controls analogous to manual scoring. 
Additionally, the inter-study differences we have observed for 
MMC and MMS cannot be attributed to the scoring methodol-
ogy. Although Metafer appeared to slightly under-predict micro-
nucleus frequency in general, the only statistically significant 
difference between the two methodologies occurred at 10 µg/ml 
etoposide. Here, manual scoring showed this to be significantly 
different to the solvent control. Upon investigation, it appeared 
that the magnification used for scanning slides might influence 
the number of both binucleates and micronuclei detected by the 
Metafer. For example, use of the ×20 objective appears to enable 
greater visual clarity and could, therefore, give results closer to 
manual micronucleus detection than lower magnifications, such 
as ×10. This may partly be due to the relatively small nuclear 
diameter of EpiDerm™-derived cells, when compared with that 
of the lymphoblastoid cell lines that our Metafer system is opti-
mised to detect. Further, P&G uses ×400 magnification to iden-
tify micronuclei, while ×100 is used for by-eye confirmation 
for Metafer; this difference may partly explain the difference 
observed between Metafer and manual in this case. It would also 
be possible to, in future, experiment with a lower power objec-
tive, more commonly used in manual scoring, with Metafer 
for by-eye confirmation (e.g. ×60). An interesting observation 
resulting from this collaboration was that P&G’s 6 µg/ml MMC 
produced a micronucleus frequency of 4.4% following Metafer 
analysis (Figure 8), compared to 0.7% at Swansea. This indicates 
that further investigation may be required, perhaps including 
inter-laboratory validations. However, as mentioned previously, 
a highly significant difference was observed between historical 
solvent and positive control micronucleus frequencies.
Based on the preliminary investigations outlined in this 
study, it is recommended that further optimisation be completed 
prior to Metafer being incorporated into this assay routinely. 
However, these findings are encouraging and provide a solid 
starting point for combining objective micronucleus scoring 
with the RSMN assay, giving increased statistical power from 
analysis of a greater number of cells. Combining 3D skin mod-
els with automated micronucleus detection could, therefore, be 
a major step forward in the quest for animal replacements.
Correlation with 2D data
The parameters defining non-linearity used here serve as a 
comparison between 2D and 3D systems and not to define 
Fig. 7. Image of polyacrylamide gel for MPG mRNA expression in the 3D EpiDerm™ models, following two topical applications of MMS (n = 2). Lane 1: 
DNA ladder. Lane 2: empty. Lanes 3 and 4: 10 µl acetone. Lanes 5 and 6: 1000 µg/ml (31.25 µg/cm2). Lanes 7 and 8: 1900 µg/ml (59.375 µg/cm2). Lane 9: PCR 
positive control (β-actin). Lane 10: positive control, using RNA from TK6 cells. Lane 11: PCR negative control.
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thresholds. The mechanisms of such thresholds are beyond the 
scope of this study, although differences in LOGELs between 
2D and 3D maybe due to assay sensitivity, differential cellular 
dynamics (cell cycle time), repair capacities and checkpoint 
proficiencies, or different diffusion and reaction kinetics owing 
to the different microenvironments. Comparisons between 
LOGELs obtained in 2D cell culture, such as cells grown in 
suspension, to those of 3D EpiDerm™ models, may, however, 
be informative for evaluation of the RSMN assay. For MMS, 
it is apparent that 2D cell culture models are more susceptible 
to MMS than the 3D models used here (Figure 6). Around 7×, 
more chemical was required to elicit a LOGEL in 3D, for both 
topical and medium dosing, than 2D (Figure 9). Interestingly, 
approximately the same overall mass elicited a LOGEL in 2D 
(0.1 µg) and 3D topical (0.096 µg) for MMC (Table I). Whereas 
topical dosing involves concentrating the chemical over a small 
area, treatment within a 2D culture disperses chemical over 
a relatively large volume. This emphasises the difficulty of 
accurately extrapolating between 2D and 3D topical exposure, 
due to the contrasting kinetics of the two approaches. A more 
accurate comparison would be between 2D and 3D medium 
exposure, as in both cases, the chemical is diluted in medium.
Interestingly, a similar mass of MMS was required to elicit 
a LOGEL in both medium (36 µg) and topical (35 µg) treat-
ments in EpiDerm™ (Table I). This perhaps suggests that 
EpiDerm™’s stratum corneum has limited barrier function, 
as observed previously (19). This also provides cause to ques-
tion the suitability of the solvent, which may enhance the per-
meability of MMS through barrier disruption (20). However, 
this may also be explained by chemical on the topical surface 
being highly concentrated in a small area, yet in medium, it 
is relatively sparse. Therefore, it is necessary to acknowledge 
that these are extremely different dosing routes and that fur-
ther investigation with other chemicals is required. With further 
study, it is possible that ‘sensitivity factors’ could be defined 
and applied for comparing 2D and 3D, if consistent levels of 
variation in LOGELs between the two systems are identified.
Our experience of using the models
H&E stained tissue sections (Figure  1) demonstrated that 
the stratum corneum thickened over the course of the assay, 
supporting the models as functional, dynamic representations 
of the human epidermis. Further, our observations when using 
the models demonstrated that specific characteristics, such as 
colour, are important indicators of cell yield and overall health 
of the models. As mentioned previously, maintaining a dry 
topical surface is crucial for ensuring that the models remain 
at their optimum. This became apparent when we questioned 
the suitability of using the recommended solvent, acetone, 
by applying a supposedly more biologically compatible 
alternative, water. When water alone was applied topically, 
there was a substantial reduction in the binucleate frequency, 
suggesting that the layer of water remaining on the topical 
surface prevented cell proliferation and impeded cellular gas 
exchange. Additionally, a positive dose of 6 µg/ml MMC in 
acetone was negative in water for micronucleus induction. 
Whether this is due to water inhibition or acetone potentiation 
is still unknown. Potential reactivity of acetone with the test 
article should be realized and may explain the negative result 
for H2O2 in Figure 5 (21). Referring to this, a positive result 
was expected given that H2O2 has been shown to cause strand 
breaks in the comet assay in HaCaT transformed keratinocytes 
(22). Additionally, micronucleus induction following treatment 
with H2O2 in human lymphoblastoid cell lines has previously 
been observed by our research group (10). Whether our 
negative result is an artefact of the RSMN assay or whether 
it demonstrates a true null effect in the micronucleus assay 
through either detoxification (11), efficient oxidative adduct 
repair or lack of exposure to the deeper epidermal layers is 
unknown. Indeed, clastogenic effects may be diminished by 
reaction of H2O2 with dead cellular matter prior to entry into 
the cells, and it is possible that chemicals derived from these 
reactions contributed to reduction in binucleate frequency. 
Whether there is a full complement of DNA repair and 
Fig. 8. Comparison of micronucleus frequencies using manual scoring, 
performed at P&G (USA), and Metafer scoring approaches performed at 
Swansea University. Three chemicals were investigated: (A) MMC, (B) 
N-ethyl-N-nitrosourea (ENU) and (C) Etoposide. Both scoring methodologies 
gave similar outcomes, with asterisks (*) indicating significant increases 
in micronucleus frequency relative to the solvent control. Corresponding 
binucleate frequency is also shown.
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antioxidant capacities or sufficient barrier protection from the 
stratum corneum remains to be seen. In this instance, medium 
application of H2O2 may be informative.
Mononucleate assay
The mononucleate assay appeared to be less sensitive than the 
binucleate assay for detection of micronuclei. This may be due 
to the binucleate assay only considering cells that had divided 
since the addition of cytoB, whereas the mononucleate assay 
indiscriminately considers all intact cells (23). Consequently, 
cells that are senescent, in cell cycle arrest, or pre-apoptotic 
during the assay, would not have undergone nuclear division 
since, and indeed due to, chemical exposure (24). Such cells 
will not contain micronuclei, regardless of the presence of 
sufficient chromosomal damage (24). This may also occur 
when the culture conditions do not allow an optimal number 
of dividing cells for analysis (24). As a result, this is likely to 
lead to underestimation of micronucleus frequency, generating 
false-negative results (23). Another disadvantage of the 
mononucleate assay was that binucleate frequencies could 
not be obtained for these tissues, due to no cytoB to inhibit 
cytokinesis.
Gene expression
Evidence of the mRNA of the DNA repair enzyme, MPG, in 
tissues of different treatments, indicates that these models are 
likely to be DNA repair competent. This develops the findings 
of previous studies of mRNA expression in EpiDerm™, which 
confirmed comparable expression of xenobiotic metabolising 
enzymes between human skin and EpiDerm™ (5). However, 
as presence of mRNA is not necessarily indicative of protein 
or DNA repair activity, further investigation is required. MPG 
expression in EpiDerm™ appears slightly greater than for 
human lymphoblastoid cell line TK6 (Figure  7, Lane 10), 
suggesting possibly only subtle differences in repair capacity 
of cell lines and 3D models. Studies of gene expression in 
EpiDerm™ are particularly important for comparisons with 
normal human skin, as well as comparisons to existing in vivo 
test models. It was also possible to quantify protein from the 
models by western blotting of total protein extracts (data not 
shown).
Conclusions
We have made advancement in the RSMN assay through 
inclusion of an automated scoring procedure. Although our data 
are preliminary, and further validation is required to confirm 
that Metafer correlates reproducibly with manual scoring, it 
is clear that there is potential for incorporating the Metafer 
into this assay. Further optimisation of the ×20 objective in 
slide scanning by Metafer would be beneficial if the Metafer’s 
potential in this assay is to be maximised. Combining the assay 
with the major statistical and practical benefits of Metafer may 
Fig. 9. (A) Summary of the differences in micronucleus induction in different 2D and 3D cell culture systems in terms of total µg applied to the system. The 2D 
dose–response referred to is shown in Figure 9B. (B) Micronucleus frequency in mononucleate human lymphoblastoid TK6 cells, following 24 h treatment with 
MMS and 24 h recovery post-treatment (n = 3). A LOGEL was identified at 0.5 µg/ml (P < 0.05). *Represents a P ≤ 0.05 relative to the untreated control.
Table I. Standardisation of doses of MMC and MMS between 2D and 3D cell culture systems to correct for differences in dose regimes.
MMC MMS
2D 3D (topical) 2D 3D (topical) 3D (medium)
LOGEL (µg/ml) 0.01 4.8 0.5 1750 20
Final concentration (µg/ml) 0.01 9.6 0.5 3500 40
Total µg applied to system 0.1 0.096 5 35 36
LOGEL for MMC in 2D represents that of L5178Y tk+/− cells (25). LOGEL for 2D was multiplied by 10 to account for 10 ml culture, whereas 3D doubled to 
account for the two doses administered during the RSMN assay. Adjustments for total mass (µg) applied to system due to two 10 µl applications on the topical 
surface and 900 µl volume of medium.
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play a significant role in the reduction of unnecessary animal 
tests in toxicology. We have also demonstrated that the assay 
is reproducible and possibly less susceptible to producing 
misleading positives than existing in vitro tests, perhaps 
providing an alternative follow-up for positives generated by 
standard in vitro genotoxicity assays.
Supplementary data
Supplementary Figure 1 is available at Mutagenesis Online. 
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